+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca improves serum albumin levels in chronic active hepatitis



Ursodeoxycholic acid udca improves serum albumin levels in chronic active hepatitis



Gastroenterology 98(5 Part 2): A606




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144944

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid udca improves serum protein level in patients with chronic active hepatitis. Hepatology 12(4 Part 2): 998, 1990

Effect of ursodeoxycholic acid udca on serum enzymes and liver histology in patients with chronic active hepatitis cah. Journal of Hepatology 13(Suppl. 2): S92, 1991

Ursodeoxycholic acid udca decreases serum cholesterol levels ameliorates symptoms and improves biochemical parameters in pediatric patients with chronic intrahepatic cholestasis. Gastroenterology 98(5 Part 2): A566, 1990

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study. European Journal of Clinical Pharmacology 40(5): 473-476, 1991

Ursodeoxycholic acid udca in chronic active hepatitis results of a controlled trial. Journal of Hepatology 13(Suppl. 2): S104, 1991

Effect of ursodeoxycholic acid udca on liver function lf in patients with chronic active hepatitis and cirrhosis. European Journal of Clinical Investigation 20(2 Part 2): A62, 1990

Ursodeoxycholic acid udca in active cirrhosis influence of hepatitis c virus hcv infection. Journal of Hepatology 13(Suppl. 2): S139, 1991

Efficacy of ursodeoxycholic acid in lowering alanine aminotransferase and gamma glutamyl transpeptidase serum levels in patients with chronic active hepatitis and biliary cirrhosis. Current Therapeutic Research 47(1): 62-66, 1990

Efficacy of ursodeoxycholic acid (UDCA) in the treatment of chronic alcoholic hepatitis. Klinicheskaia Meditsina 76(5): 26-28, 1998

Ursodeoxycholic acid udca in chronic hepatitis a double blind multicenter clinical trial. Gastroenterology 100(5 Part 2): 719, 1991

Ursodeoxycholic acid udca treatment improves liver disease and nutritional state in cystic fibrosis cf patients with chronic cholestasis. Gastroenterology 96(5 Part 2): A586, 1989

Serum bile acid levels and distribution in primary biliary cirrhosis pbc effect of ursodeoxycholic acid udca therapy. Gastroenterology 100(5 Part 2): A786, 1991

Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection. Hepatology Research 39(1): 21-30, 2008

Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study. Hepatology 13(2): 339-344, 1991

Effect of ursodeoxycholic acid on serum liver enzymes and bile acid composition of serum and bile in patients with chronic active hepatitis C. Hepatology 26(4 Part 2): 573A, 1997